Management of cutaneous lupus erythematosus with low-dose methotrexate: indication for modulation of inflammatory mechanisms. [electronic resource]
- Rheumatology international 1998
- 59-62 p. digital
Publication Type: Journal Article
0172-8172
10.1007/s002960050058 doi
Administration, Oral Adult Aged Aged, 80 and over Antirheumatic Agents--therapeutic use Autoantibodies--blood Dose-Response Relationship, Drug Female Humans Lupus Erythematosus, Cutaneous--drug therapy Male Methotrexate--therapeutic use Middle Aged Retrospective Studies Treatment Outcome